FDA gives nod to first fully-removable percutaneous peripheral
Price: $ 79.99
4.9(733)
SPR Therapeutics has developed a peripheral nerve stimulation system that is placed percutaneously through the skin instead of being implanted and which can be completely removed from the body after therapy period.
News - Interventional News
Approvals & refusals – BIBA Medtech Insights
Latest News Archives - Page 2 of 3 - Interventional News
willdate, Author at Cardiac Rhythm News
FDA approves Nevro's Senza system to treat chronic pain with diabetic neuropathy - MassDevice
Arterial puncture site management
Microparticles: biogenesis, characteristics and intervention therapy for cancers in preclinical and clinical research, Journal of Nanobiotechnology
NeuroNews issue 50 - US by BIBA Publishing - Issuu
Design principles of microneedles for drug delivery and sampling applications - ScienceDirect
NeuroNews issue 50 - US by BIBA Publishing - Issuu
Role of Immunological Cells in Hepatocellular Carcinoma Disease and Associated Pathways
CFR 2022 – Volume 8 by Radcliffe Cardiology - Issuu
Percutaneous peripheral nerve stimulation for the treatment of chronic neuropathic postamputation pain: a multicenter, randomized, placebo-controlled trial